Melatonin for the prevention and treatment of jet lag
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: : Jet-lag commonly affects air travellers who cross several time zones. It results from the body's internal rhythms being out of step with the day-night cycle at the destination. Melatonin is a pineal hormone that plays a central part in regulating bodily rhythms and has been used as a drug to re-align them with the outside world. OBJECTIVES: : To assess the effectiveness of oral melatonin taken in different dosage regimens for alleviating jet-lag after air travel across several time zones. SEARCH STRATEGY: : We searched the Cochrane Controlled Trials Register, MEDLINE, EMBASE, PsychLit and Science Citation Index electronically, and the journals 'Aviation, Space and Environmental Medicine' and 'Sleep' by hand. We searched citation lists of relevant studies for other relevant trials. We asked principal authors of relevant studies to tell us about unpublished trials. Reports of adverse events linked to melatonin use outside randomised trials were searched for systematically in 'Side Effects of Drugs' (SED) and SED Annuals, 'Reactions Weekly', MEDLINE, and the adverse drug reactions databases of the WHO Uppsala Monitoring Centre (UMC) and the US Food & Drug Administration. SELECTION CRITERIA: : Randomised trials in airline passengers, airline staff or military personnel given oral melatonin, compared with placebo or other medication. Outcome measures should consist of subjective rating of jet-lag or related components, such as subjective wellbeing, daytime tiredness, onset and quality of sleep, psychological functioning, duration of return to normal, or indicators of circadian rhythms. DATA COLLECTION AND ANALYSIS: : Ten trials met the inclusion criteria. All compared melatonin with placebo; one in addition compared it with a hypnotic, zolpidem. Nine of the trials were of adequate quality to contribute to the assessment, one had a design fault and could not be used in the assessment. Reports of adverse events outside trials were found through MEDLINE, 'Reactions Weekly', and in the WHO UMC database. MAIN RESULTS: : Nine of the ten trials found that melatonin, taken close to the target bedtime at the destination (10pm to midnight), decreased jet-lag from flights crossing five or more time zones. Daily doses of melatonin between 0.5 and 5mg are similarly effective, except that people fall asleep faster and sleep better after 5mg than 0.5mg. Doses above 5mg appear to be no more effective. The relative ineffectiveness of 2mg slow-release melatonin suggests that a short-lived higher peak concentration of melatonin works better. Based on the review, the number needed to treat (NNT) is 2. The benefit is likely to be greater the more time zones are crossed, and less for westward flights. The timing of the melatonin dose is important: if it is taken at the wrong time, early in the day, it is liable to cause sleepiness and delay adaptation to local time. The incidence of other side effects is low. Case reports suggest that people with epilepsy, and patients taking warfarin may come to harm from melatonin. REVIEWER'S CONCLUSIONS: : Melatonin is remarkably effective in preventing or reducing jet-lag, and occasional short-term use appears to be safe. It should be recommended to adult travellers flying across five or more time zones, particularly in an easterly direction, and especially if they have experienced jet-lag on previous journeys. Travellers crossing 2-4 time zones can also use it if need be. The pharmacology and toxicology of melatonin needs systematic study, and routine pharmaceutical quality control of melatonin products must be established. The effects of melatonin in people with epilepsy, and a possible interaction with warfarin, need investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Psychology of Physical Symptoms
Pennebaker, J. W. (1982) · Springer eBooks · doi:10.1007/978-1-4613-8196-9 · Cited by 1,758
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
Meyler's Side Effects of Drugs
(2016) · Elsevier eBooks · doi:10.1016/c2009-1-62477-1 · Cited by 756
Melatonin Shifts Human Orcadian Rhythms According to a Phase-Response Curve
Lewy, A. J., Ahmed, S., Jackson, J. M. L., & Sack, R. L. (1992) · Chronobiology International · doi:10.3109/07420529209064550 · Cited by 693
Occupational Medicine: State of the Art Reviews
AW, C. (1988) · Occupational Medicine · doi:10.1093/occmed/38.3.90-b · Cited by 537
Ur, E. (1991) · Postgraduate Medical Journal · doi:10.1136/pgmj.67.787.497 · Cited by 345
Some effects of jet-lag and their alleviation by melatonin
ARENDT, J., ALDHOUS, M., ENGLISH, J., MARKS, V., ARENDT, J. H., MARKS, M., & FOLKARD, S. (1987) · Ergonomics · doi:10.1080/00140138708966031 · Cited by 276
Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial.
Arendt, J., Aldhous, M., & Marks, V (1986) · BMJ · doi:10.1136/bmj.292.6529.1170 · Cited by 269
Effect of melatonin on jet lag after long haul flights.
Petrie, K., Conaglen, J. V., Thompson, L., & Chamberlain, K. (1989) · BMJ · doi:10.1136/bmj.298.6675.705 · Cited by 243
Self-citationEfficacy of Melatonin Treatment in Jet Lag, Shift Work, and Blindness
Arendt, J., Skene, D. J., Middleton, B., Lockley, S. W., & Deacon, S. (1997) · Journal of Biological Rhythms · doi:10.1177/074873049701200616 · Cited by 239
Cited by
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Sleep, insomnia, and depression
Riemann, D., Krone, L. B., Wulff, K., & Nissen, C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 819
Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Arendt, J., & Skene, D. J. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.05.002 · Cited by 629
Sleep and the athlete: narrative review and 2021 expert consensus recommendations
Walsh, N. P., Halson, S. L., Sargent, C., Roach, G. D., Nédélec, M., Gupta, L., Leeder, J., Fullagar, H. H., Coutts, A. J., Edwards, B. J., et al. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102025 · Cited by 571
Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Vohra, S., Klassen, T. P., & Baker, G. (2006) · BMJ · doi:10.1136/bmj.38731.532766.f6 · Cited by 454
Auger, R. R., Burgess, H. J., Emens, J. S., Deriy, L. V., Thomas, S. M., & Sharkey, K. M. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5100 · Cited by 438
Jet lag: trends and coping strategies
Waterhouse, J., Reilly, T., Atkinson, G., & Edwards, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60529-7 · Cited by 430
Arendt, J. (2006) · Chronobiology International · doi:10.1080/07420520500464361 · Cited by 381
Metabolism of melatonin by human cytochromes p450
Ma, X., Idle, J. R., Krausz, K. W., & Gonzalez, F. J. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002410 · Cited by 319
“MEL has been evaluated as a therapeutic agent in a number of conditions, including sleep disturbance, jet lag and metastatic cancer (Lissoni et al., 1989; Herxheimer and Petrie, 2002; Singer et al., 2003).”
BackgroundMelatonin: Characteristics, Concerns, and Prospects
Arendt, J. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730405277492 · Cited by 312
Rensing, L., & Ruoff, P. (2002) · Chronobiology International · doi:10.1081/cbi-120014569 · Cited by 306
McCune, L. M., Kubota, C., Stendell-Hollis, N. R., & Thomson, C. A. (2010) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903001719 · Cited by 295
Touitou, Y., Touitou, D., & Reinberg, A. (2016) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2017.05.001 · Cited by 290
Circadian Clocks and Metabolism
Marcheva, B., Ramsey, K. M., Peek, C. B., Affinati, A., Maury, E., & Bass, J. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25950-0_6 · Cited by 282
“Conversely, melatonin treatment following the endogenous onset of secretion is often useful to improve westbound jetlag (Herxheimer and Petrie 2002).”
BackgroundDefining ‘nutraceuticals’: neither nutritious nor pharmaceutical
Aronson, J. K. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12935 · Cited by 273
A clinical approach to circadian rhythm sleep disorders
Barion, A., & Zee, P. C. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.11.017 · Cited by 214
“5–5 mg taken close to local bedtime for up to four days [117].”
BackgroundRichter, H. G., Hansell, J. A., Raut, S., & Giussani, D. A. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00671.x · Cited by 188
“The dose of melatonin was adopted from other studies showing potent actions on the expression of antioxidant enzymes [15] and it was also less than the maximal dose recommended for overcoming jet lag in humans [33].”
BackgroundMethodSMITS, M. G., van STEL, H. F., van der HEIJDEN, K., MEIJER, A. M., COENEN, A. M. L., & KERKHOF, G. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000085756.71002.86 · Cited by 187
Role of the Melatonin System in the Control of Sleep: Therapeutic Implications
Pandi-Perumal, S. R., Srinivasan, V., Spence, D. W., & Cardinali, D. P. (2007) · CNS Drugs · doi:10.2165/00023210-200721120-00004 · Cited by 179
“One major inconvenience is that mewith placebo.[227] latonin has not obtained a regulatory approval as a Melatonin treatment is remarkably well tolerated, drug, with the consequence that preparations sold as even in very high doses and in individuals with a food supplement do not always accomplish the various diseases.”
BackgroundMinich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176
“In a Cochrane review, nine out of ten trials found that melatonin effectively reduced jet lag symptoms in travelers, especially if traveling eastward or over five time zones [74].”
BackgroundEndocrine Effects of Circadian Disruption
Bedrosian, T. A., Fonken, L. K., & Nelson, R. J. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105102 · Cited by 170
“For example, melatonin has been used to treat jet lag (178), sleep disorders (179), and circadian rhythm disturbances in the elderly (180) and shift workers (however, see Reference 181).”
BackgroundClinical aspects of human circadian rhythms
Klerman, E. B. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730405278353 · Cited by 139
Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
Menczel Schrire, Z., Phillips, C. L., Chapman, J. L., Duffy, S. L., Wong, G., D’Rozario, A. L., Comas, M., Raisin, I., Saini, B., Gordon, C. J., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12782 · Cited by 133
Chen, W. Y., Giobbie-Hurder, A., Gantman, K., Savoie, J., Scheib, R., Parker, L. M., & Schernhammer, E. S. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2944-4 · Cited by 130
Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs
Srinivasan, V., Singh, J., Pandi-Perumal, S. R., Brown, G. M., Spence, D. W., & Cardinali, D. P. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0065-y · Cited by 129
What keeps us awake?–the role of clocks and hourglasses, light, and melatonin
Cajochen, C., Chellappa, S., & Schmidt, C. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)93003-1 · Cited by 73
“controlled and placebo-uncontrolled studies that have been summarized in a Cochrane (Herxheimer and Petrie, 2002).”
Aiding sleep in type 2 diabetes: therapeutic considerations
Tan, X., van Egmond, L., Chapman, C. D., Cedernaes, J., & Benedict, C. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30233-4 · Cited by 72
Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
Liira, J., Verbeek, J. H., Costa, G., Driscoll, T. R., Sallinen, M., Isotalo, L. K., & Ruotsalainen, J. H. (2015) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.20151331t1 · Cited by 50
Circadian rhythm sleep-wake phase disorders
Culnan, E., McCullough, L. M., & Wyatt, J. K. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.04.003 · Cited by 42
Metadata
- Authors
- Herxheimer, A., & Petrie, K. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2002-04-22
- Volume
- 2010
- Issue
- 1
- Pages
- CD001520-CD001520
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1892729147
- Cited by
- 426
- References
- 26
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.